![Sean Smith](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Sean Smith
No más puestos en curso
Historial de carrera de Sean Smith
Antiguos cargos conocidos de Sean Smith.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
APTEVO THERAPEUTICS INC. | Comptroller/Controller/Auditor | 01/04/2017 | 01/08/2019 |
NEUROGENE INC. | Comptroller/Controller/Auditor | 01/10/2019 | 31/03/2023 |
Director Financiero/CFO | 31/03/2023 | - |
Formación de Sean Smith.
University of North Texas | Graduate Degree |
University of Washington | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 5 |
Operativa
Comptroller/Controller/Auditor | 2 |
Director of Finance/CFO | 1 |
Graduate Degree | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
APTEVO THERAPEUTICS INC. | Health Technology |
Empresas privadas | 1 |
---|---|
Neoleukin Therapeutics, Inc.
![]() Neoleukin Therapeutics, Inc. BiotechnologyHealth Technology Neoleukin Therapeutics, Inc. operates as a biopharmaceutical company, which computational methods to design de novo protein therapeutics. The firm address significant medical needs in oncology, inflammation, and autoimmunity. Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA. | Health Technology |
- Bolsa de valores
- Insiders
- Sean Smith
- Experiencia